●Advanced sequencing technologies: methods and goals. Shendure, J. et al. New techniques will soon make the sequencing of an individual's genome routine practice. Nature Reviews Genetics May (2004)

●Neurocognitive enhancement: what can we do and what should we do? Farah, M. J. et al. Nature Reviews Neuroscience May (2004)

●Experimental therapeutics in transgenic mouse models of Huntington's disease. Beal, M. F. & Ferrante, R. J. Nature Reviews Neuroscience May (2004)

●The future of anti-infective products in animal health. Shryock, T. R. Nature Reviews Microbiology May (2004)

●Control of virus infection by soluble factors of the immune response: valuable lessons from HIV-1. DeVico, A. L. & Gallo, R. C. Nature Reviews Microbiology May (2004)

●Making prevention pay. Dove, A. Several biotechs have established new vaccine and anti-infective programmes to take advantage of increased funding for biodefense. Nature Biotechnology April (2004)

●Putting the heat on ALS. Benn, S. C. & Brown, R. H. Jr Symptoms of neurodegeneration are improved by enhancing the heat-shock response in a mouse model of amyotrophic lateral sclerosis, even when treatment begins after disease onset. Nature Medicine April (2004)

●The HapMap project and its application to genetic studies of drug response. Deloukas, P. & Bentley, D. The Pharmacogenomics Journal April (2004)

●Neurovascular regulation in the normal brain and in Alzheimer's disease. Iadecola, C. Nature Reviews Neuroscience May (2004)

●Special focus: targeted therapies.Nature Reviews Cancer May (2004)

●The proteasome: a suitable antineoplastic target. Adams, J.

●The TOR pathway: a target for cancer therapy. Bjornsti, M.-A. & Houghton, P. J.

●The discovery of receptor tyrosine kinases: targets for cancer therapy. Gschwind, A., Fischer, O. M. & Ullrich, A.